Israel Englander’s Valion Bio VBIO Stock Holding History

Israel Englander’s Portfolio VBIO Stock Details VBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18	Closed	-$3.2K	–	6565
2023 Q2	$3.2K	Buy	+18	New	+$3.86K	﹤0.01%	5910

Other funds holding VBIO

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Israel Englander's VBIO Position: Q3 2023 in Review

Israel Englander sold out of Valion Bio (VBIO) in Q3 2023, closing a stake of 18 shares — an estimated $3.2K sold.

Israel Englander first reported a position in VBIO in Q2 2023 and held it in 1 quarter. The position peaked at $3.2K in Q2 2023. 6 funds tracked by Wall St. Rank hold VBIO as of Q3 2023.

Israel Englander reported no remaining Valion Bio position as of Q3 2023 after selling out during the quarter.
Israel Englander sold 18 Valion Bio shares in Q3 2023, an estimated $3.2K.
Israel Englander first reported a position in Valion Bio in Q2 2023 and held it in 1 quarter.
Israel Englander's Valion Bio position peaked at $3.2K in Q2 2023.
6 funds tracked by Wall St. Rank held Valion Bio as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.